(2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propyl-ethylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5S)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butylsulfinylmethyl]oxolane-3,4-diol;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-N-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butyl]methanesulfonamide;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-4-(6-tert-butyl-1H-benzimidazol-2-yl)-N-propan-2-ylbutanamide

C134H182N36O19S2 — CID 159606567

About (2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propyl-ethylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5S)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butylsulfinylmethyl]oxolane-3,4-diol;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-N-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butyl]methanesulfonamide;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-4-(6-tert-butyl-1H-benzimidazol-2-yl)-N-propan-2-ylbutanamide

(2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propyl-ethylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5S)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butylsulfinylmethyl]oxolane-3,4-diol;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-N-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butyl]methanesulfonamide;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-4-(6-tert-butyl-1H-benzimidazol-2-yl)-N-propan-2-ylbutanamide (PubChem CID 159606567) has the molecular formula C134H182N36O19S2 and a molecular weight of 2665.30 g/mol. Its IUPAC name is (2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propyl-ethylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5S)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butylsulfinylmethyl]oxolane-3,4-diol;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-N-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butyl]methanesulfonamide;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-4-(6-tert-butyl-1H-benzimidazol-2-yl)-N-propan-2-ylbutanamide.

Molecular Properties

• Compound Name: (2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propyl-ethylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5S)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butylsulfinylmethyl]oxolane-3,4-diol;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-N-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butyl]methanesulfonamide;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-4-(6-tert-butyl-1H-benzimidazol-2-yl)-N-propan-2-ylbutanamide
• PubChem CID: 159606567
• Molecular Formula: C134H182N36O19S2
• Molecular Weight: 2665.30 g/mol
• Exact Mass: 2663.38
• IUPAC Name: (2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propyl-ethylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5S)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butylsulfinylmethyl]oxolane-3,4-diol;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-N-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butyl]methanesulfonamide;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-4-(6-tert-butyl-1H-benzimidazol-2-yl)-N-propan-2-ylbutanamide
• SMILES: CC(C)(C)c1ccc2nc(CCCCN(C[C@H]3O[C@@H](n4cnc5c(N)ccnc54)[C@H](O)[C@@H]3O)S(C)(=O)=O)[nH]c2c1.CC(C)(C)c1ccc2nc(CCCCS(=O)C[C@H]3O[C@@H](n4cnc5c(N)ccnc54)[C@H](O)[C@@H]3O)[nH]c2c1.CC(C)(C)c1ccc2nc(NCCCNC[C@H]3O[C@@H](n4cnc5c(N)ccnc54)[C@H](O)[C@@H]3O)[nH]c2c1.CC(C)N(C[C@H]1O[C@@H](n2cnc3c(N)ccnc32)[C@H](O)[C@@H]1O)C(=O)CCCc1nc2ccc(C(C)(C)C)cc2[nH]1.CCN(CCCNc1nc2ccc(C(C)(C)C)cc2[nH]1)C[C@H]1O[C@@H](n2cnc3c(N)ccnc32)[C@H](O)[C@@H]1O
• InChI: InChI=1S/C29H39N7O4.C27H38N8O3.C27H37N7O5S.C26H34N6O4S.C25H34N8O3/c1-16(2)35(23(37)8-6-7-22-33-19-10-9-17(29(3,4)5)13-20(19)34-22)14-21-25(38)26(39)28(40-21)36-15-32-24-18(30)11-12-31-27(24)36;1-5-34(12-6-10-30-26-32-18-8-7-16(27(2,3)4)13-19(18)33-26)14-20-22(36)23(37)25(38-20)35-15-31-21-17(28)9-11-29-24(21)35;1-27(2,3)16-8-9-18-19(13-16)32-21(31-18)7-5-6-12-33(40(4,37)38)14-20-23(35)24(36)26(39-20)34-15-30-22-17(28)10-11-29-25(22)34;1-26(2,3)15-7-8-17-18(12-15)31-20(30-17)6-4-5-11-37(35)13-19-22(33)23(34)25(36-19)32-14-29-21-16(27)9-10-28-24(21)32;1-25(2,3)14-5-6-16-17(11-14)32-24(31-16)29-9-4-8-27-12-18-20(34)21(35)23(36-18)33-13-30-19-15(26)7-10-28-22(19)33/h9-13,15-16,21,25-26,28,38-39H,6-8,14H2,1-5H3,(H2,30,31)(H,33,34);7-9,11,13,15,20,22-23,25,36-37H,5-6,10,12,14H2,1-4H3,(H2,28,29)(H2,30,32,33);8-11,13,15,20,23-24,26,35-36H,5-7,12,14H2,1-4H3,(H2,28,29)(H,31,32);7-10,12,14,19,22-23,25,33-34H,4-6,11,13H2,1-3H3,(H2,27,28)(H,30,31);5-7,10-11,13,18,20-21,23,27,34-35H,4,8-9,12H2,1-3H3,(H2,26,28)(H2,29,31,32)/t21-,25-,26-,28-;20-,22-,23-,25-;20-,23-,24-,26-;19-,22-,23-,25-,37?;18-,20-,21-,23-/m11111/s1
• InChIKey: MMDQADSBWSVCGF-KXSCOVFFSA-N
• XLogP: 12.26
• TPSA: 789.59 Ų
• H-Bond Donors: 23
• H-Bond Acceptors: 48
• Rotatable Bonds: 42
• Heavy Atoms: 191
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2665.30
LogP ≤ 5	12.26
H-Bond Donors ≤ 5	23
H-Bond Acceptors ≤ 10	48

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of (2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propyl-ethylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5S)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butylsulfinylmethyl]oxolane-3,4-diol;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-N-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butyl]methanesulfonamide;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-4-(6-tert-butyl-1H-benzimidazol-2-yl)-N-propan-2-ylbutanamide?

The IUPAC name of (2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propyl-ethylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5S)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butylsulfinylmethyl]oxolane-3,4-diol;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-N-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butyl]methanesulfonamide;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-4-(6-tert-butyl-1H-benzimidazol-2-yl)-N-propan-2-ylbutanamide (CID 159606567) is (2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propyl-ethylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5S)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butylsulfinylmethyl]oxolane-3,4-diol;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-N-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butyl]methanesulfonamide;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-4-(6-tert-butyl-1H-benzimidazol-2-yl)-N-propan-2-ylbutanamide.

What is the SMILES notation for (2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propyl-ethylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5S)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butylsulfinylmethyl]oxolane-3,4-diol;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-N-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butyl]methanesulfonamide;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-4-(6-tert-butyl-1H-benzimidazol-2-yl)-N-propan-2-ylbutanamide?

The canonical SMILES for (2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propyl-ethylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5S)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butylsulfinylmethyl]oxolane-3,4-diol;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-N-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butyl]methanesulfonamide;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-4-(6-tert-butyl-1H-benzimidazol-2-yl)-N-propan-2-ylbutanamide is CC(C)(C)c1ccc2nc(CCCCN(C[C@H]3O[C@@H](n4cnc5c(N)ccnc54)[C@H](O)[C@@H]3O)S(C)(=O)=O)[nH]c2c1.CC(C)(C)c1ccc2nc(CCCCS(=O)C[C@H]3O[C@@H](n4cnc5c(N)ccnc54)[C@H](O)[C@@H]3O)[nH]c2c1.CC(C)(C)c1ccc2nc(NCCCNC[C@H]3O[C@@H](n4cnc5c(N)ccnc54)[C@H](O)[C@@H]3O)[nH]c2c1.CC(C)N(C[C@H]1O[C@@H](n2cnc3c(N)ccnc32)[C@H](O)[C@@H]1O)C(=O)CCCc1nc2ccc(C(C)(C)C)cc2[nH]1.CCN(CCCNc1nc2ccc(C(C)(C)C)cc2[nH]1)C[C@H]1O[C@@H](n2cnc3c(N)ccnc32)[C@H](O)[C@@H]1O.

What is the InChIKey of (2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propyl-ethylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5S)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butylsulfinylmethyl]oxolane-3,4-diol;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-N-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butyl]methanesulfonamide;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-4-(6-tert-butyl-1H-benzimidazol-2-yl)-N-propan-2-ylbutanamide?

The InChIKey is MMDQADSBWSVCGF-KXSCOVFFSA-N. The full InChI is InChI=1S/C29H39N7O4.C27H38N8O3.C27H37N7O5S.C26H34N6O4S.C25H34N8O3/c1-16(2)35(23(37)8-6-7-22-33-19-10-9-17(29(3,4)5)13-20(19)34-22)14-21-25(38)26(39)28(40-21)36-15-32-24-18(30)11-12-31-27(24)36;1-5-34(12-6-10-30-26-32-18-8-7-16(27(2,3)4)13-19(18)33-26)14-20-22(36)23(37)25(38-20)35-15-31-21-17(28)9-11-29-24(21)35;1-27(2,3)16-8-9-18-19(13-16)32-21(31-18)7-5-6-12-33(40(4,37)38)14-20-23(35)24(36)26(39-20)34-15-30-22-17(28)10-11-29-25(22)34;1-26(2,3)15-7-8-17-18(12-15)31-20(30-17)6-4-5-11-37(35)13-19-22(33)23(34)25(36-19)32-14-29-21-16(27)9-10-28-24(21)32;1-25(2,3)14-5-6-16-17(11-14)32-24(31-16)29-9-4-8-27-12-18-20(34)21(35)23(36-18)33-13-30-19-15(26)7-10-28-22(19)33/h9-13,15-16,21,25-26,28,38-39H,6-8,14H2,1-5H3,(H2,30,31)(H,33,34);7-9,11,13,15,20,22-23,25,36-37H,5-6,10,12,14H2,1-4H3,(H2,28,29)(H2,30,32,33);8-11,13,15,20,23-24,26,35-36H,5-7,12,14H2,1-4H3,(H2,28,29)(H,31,32);7-10,12,14,19,22-23,25,33-34H,4-6,11,13H2,1-3H3,(H2,27,28)(H,30,31);5-7,10-11,13,18,20-21,23,27,34-35H,4,8-9,12H2,1-3H3,(H2,26,28)(H2,29,31,32)/t21-,25-,26-,28-;20-,22-,23-,25-;20-,23-,24-,26-;19-,22-,23-,25-,37?;18-,20-,21-,23-/m11111/s1.

What are the key properties of (2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propyl-ethylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5S)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butylsulfinylmethyl]oxolane-3,4-diol;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-N-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butyl]methanesulfonamide;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-4-(6-tert-butyl-1H-benzimidazol-2-yl)-N-propan-2-ylbutanamide?

(2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propyl-ethylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5S)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butylsulfinylmethyl]oxolane-3,4-diol;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-N-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butyl]methanesulfonamide;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-4-(6-tert-butyl-1H-benzimidazol-2-yl)-N-propan-2-ylbutanamide has a molecular weight of 2665.30 g/mol, XLogP of 12.26, 42 rotatable bonds, 23 hydrogen bond donors, and 48 hydrogen bond acceptors.

Where does this data come from?

All data for (2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[[3-[(6-tert-butyl-1H-benzimidazol-2-yl)amino]propyl-ethylamino]methyl]oxolane-3,4-diol;(2R,3R,4S,5S)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butylsulfinylmethyl]oxolane-3,4-diol;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-N-[4-(6-tert-butyl-1H-benzimidazol-2-yl)butyl]methanesulfonamide;N-[[(2R,3S,4R,5R)-5-(7-aminoimidazo[4,5-b]pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-4-(6-tert-butyl-1H-benzimidazol-2-yl)-N-propan-2-ylbutanamide is sourced from PubChem (CID 159606567), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).